Across
- 2. The process in the previous question interacts with oral drugs by effecting their ___.
- 3. This type of drug can mask the signs of hypoglycemia.
- 5. A 26 year old male comes into the ED. He is very lethargic and very disoriented. You take his blood sugar and find that he is hypoglycemic. What type of insulin would you administer?
- 7. Thiazolidinediones (Glitazones) reduce glucose levels by _______________ cellular response to circulating insulin.
- 11. Sulfonylureas, Meglitinides, and Biguanides are just a few examples of what type of oral drug?
- 14. _____________________ stimulate pancreatic insulin release in a manner similar to the Sulfonylureas.
- 15. Diabetes mellitus is derived from the Latin word for ______ and the Greek word for _____. The term describes one of the prominent symptoms of untreated diabetes, production of large volumes of glucose-rich urine.
- 16. Risk for ___________ skin integrity related to failure to rotate insulin injection site.
- 17. You are mixing a combination of insulins. You need 10 ml of insulin. You have already pulled up 3 ml of regular insulin, how much of the NPH do you need to pull up in your syringe?
- 18. Type 1 diabetes results from the destruction of insulin-producing __________ cells.
- 19. It is the start of your shift and you give one of your patients a shot of Humalog insulin. In how many hours do you expect to be returning to said patient to give the next shot.
- 20. The most common type of diabetes. Some sources say heredity and obesity are the major factors of this type of diabetes.
- 24. _____________ inhibitors should not be given with Metformin because they interact to cause significant GI effects.
- 29. Ketoacidosis causes alterations in the metabolism of both glucose and what?
- 30. Metformin decreases liver production of glucose and enhances uptake and utilization of glucose in which type of tissue?
- 32. A 16 year old female with type II Diabetes comes into the office very concerned about how her stomach looks. You find that she has been misinformed and has been injecting herself with insulin in the same spot (lower abdomen) every day. You assess her stomach and find that her stomach is pitting in the injection spot. What do you educate her on?
- 34. The actions of these hormones tell your body to release insulin after you eat.
- 35. Ketoacidosis, if untreated, may result in _____.
- 37. A result of insulin deficiency.
- 39. Many DM drugs inhibit or suppress ___ release of glucagon by delaying gastric emptying.
- 40. A 76 year old female comes into the ED. Her daughter who is with her tells you that the she has not been eating regularly at her nursing home. Her daughter says she skipped breakfast this morning and believes did not eat much for dinner the night before. Your patient is very fatigued and anxious, has a fast heartbeat and is sweating profusely. You take her blood sugar and it is 47 mg/dL. You would chart your patient as?
- 42. Which route would you administer the insulin of the 26 year old male who is hypoglycemic.
- 43. Which of the sulfonylureas cannot be used to treat Type 1 Diabetes?
Down
- 1. Alpha-glucosidase inhibitors act on the intestine to delay the absorption of ________________.
- 4. In treating DKA, acidosis can be sorrected using what?
- 6. The pancreas produces ___ which increases plasma glucose levels. It is also administered for severe hypoglycemia.
- 8. Susie has was dianosed with _____ at the age of 9. She is not 20 years old and has been insulin dependent since the time she was diagnosed.
- 9. A 19 year old male who has had diabetes for 2 years comes in with a raised lump on his lower abdomen. You ask him if this is the spot that he normally injects himself with insulin. He replies that this is the only place he injects himself twice a day. The raised lump is called what?
- 10. Recent data have shown that this drug can prevent the onset of Type 2 Diabetes.
- 12. Hyperglycemia agents _____________________ the effects of insulin.
- 13. This condition is a serious toxic side effect of Metformin.
- 21. HOURS You administer NPH insulin to a patient. How long before this type of Intermediate insulin starts to peak?
- 22. Glitazones should be used with caution in patients with heart failure because these drugs can cause _______________________.
- 23. SCALE You have a patient that just came out of surgery who is a type II diabetic. Her blood glucose in the last three hours has not been stable. Your decide that it is best to follow the ___________ ___________ protocol and administer adjusted doses of insulin based off of her blood glucose reading every shift.
- 25. An overdose of insulin may lead to your patient falling into a __________.
- 26. Orinase, Glucotrol, and DiaBeta promote insulin release by the pancreas. What is the name of the drug class they belong to?
- 27. The FDA warns that due to this drug's ability to complement the effects of insulin, it increases the risk of insulin-induced severe hypoglycemia.
- 28. Extreme thirst, the need to urinate often, and blurry vision can be symptoms of _________________.
- 31. ___ dysfunction patients are at greater risk for hypoglycemia using meglitinides.
- 33. A new admit that has Type 11 diabetes is put on your floor. She says she if very hungry and would like to eat something soon. What type of insulin would you administer to her if she was to eat in the next 30 minutes.
- 36. There is a strong link between Type II Diabetes and ______.
- 38. __________ diabetes causes high blood sugar that can affect your pregnancy and your baby's health.
- 39. A patient comes in and is very worried about injecting herself with insulin due to fear of needles. She lives a very busy lifestyle of work and travel. She is curious if there are any other methods than using the Lantus pen she is prescribed. You would educate her on the idea of an Insulin _______.
- 41. You are educating a very petite and skinny young woman on how to inject herself with insulin. You show her that she needs to ______ her lower abdomen and inject herself with the needle at 45 degrees to ensure that she is getting the insulin in her subcutaneous tissue.